3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
5
Rectal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Cyst
2
Pain, Postoperative
2
Esophageal Squamous Cell Carcinoma
2
Visceral Pain
1
Surgical Wound Infection
1
Sigmoid Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain
1
Nutrition Disorders
1
Lung Injury
1
Liver Neoplasms
1
Klatskin Tumor
1
Intestinal Perforation
1
Insulin Resistance
1
Infections
1
Gastroparesis
1
Feeding and Eating Disorders
1
Esophageal Neoplasms
1
Dumping Syndrome
1
Diverticulosis, Colonic
1
Cholangitis
1
Biliary Tract Neoplasms
1
Interventions
Fentanyl
2
oxycodone-acetaminophen
1
Tramadol
1
Saline Solution
1
Propofol
1
Orphenadrine
1
Nefopam
1
Morphine
1
Midazolam
1
Methadone
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ketamine
1
Hydromorphone
1
Hydrocodone
1
Gabapentin
1
Ertapenem
1
Colectomy
1
Bupivacaine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diverticulosis, Colonic
×
Saline Solution
×
Gastrointestinal
×
Clear all
NCT03619538
2025-12-01
NEFOPAM
Centre Hospitalier Universitaire de NÄ«mes
Phase NA
Completed
80 enrolled